Implantable cardioverter defibrillator-related complications in the pediatric population

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue SUPPL. 2, 2009, Pages

  Shah, Maully J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Defibrillation ICD; Pediatrics

Indexed keywords

AMIODARONE;

ANTIBIOTIC THERAPY; ANXIETY; BURN SHOCK; DEFIBRILLATOR; DEPRESSION; DEVICE REMOVAL; EXERCISE TEST; HEMATOTHORAX; HUMAN; INFECTION COMPLICATION; INTERMETHOD COMPARISON; PNEUMONIA; POSTOPERATIVE COMPLICATION; REVIEW; SINUS TACHYCARDIA; SUDDEN DEATH; SUPERIOR CAVA VEIN SYNDROME; SUPRAVENTRICULAR TACHYCARDIA; VEIN OCCLUSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE; HEART FAILURE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 68249151200     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02389.x     Document Type: Review

References (28)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997 337 : 1576 1583.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial (MADIT) investigators. N Engl J Med 1996 335 : 1933 1940.
3. Silka MJ, Kron J, Dunnigan A, Dick M 2nd. Sudden cardiac death and the use of implantable cardioverter defibrillators in pediatric patients. Circulation 1993 87 : 800 807.
4. Kron J, Silka MJ, Ohm O-J, Bardy G, Benditt D. Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. Pacing Clin Electrophysiol 1994 17 : 26 30.
5. Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol 1996 77 : 524 526.
6. Chatrath R, Porter CJ, Ackerman MJ. Role of transvenous implantable cardioverter defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clint Proc 2002 77 : 226 231.
7. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. European 7219 Jewel ICD Investigators. Adverse events with transvenous implantable cardioverter defibrillators - a prospective multicenter study. Circulation 1998 98 : 663 670.
8. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005 28 : 926 932.
9. Stefanelli CB, Bradley DJ, Leroy S, Dick M 2nd., Serwer GA, Fischbach PS. Implantable cardioverter defibrillator therapy for life threatening arrhythmias in young patients. J Intervent Cardiac Electrophysiol 2002 6 : 235 244.
10. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004 15 : 72 76.
11. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008 Apr 29 51 : 1685 1691.
12. Link MS, Hill SL, Cliff DK, Swygman CA, Foote CB, Homoud MK, Wang PJ, et al. Comparison of frequency of complications of implantable cardioverter defibrillators in children versus adults. Am J Cardiol 199 83 : 263 266.
13. Uslan DZ, Baddour LM. Cardiac device infections: Getting to the heart of the matter. Curr Opin Infect Dis 2006 19 : 345 348.
14. Love CJ, Wilkoff BL, Byrd CL, Belott PH, Brinker JA, Fearnot NE, Friedman RA, et al. North American society of pacing and electrophysiology lead extraction conference faculty. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: Indications, facilities, training. Pacing Clin Electrophysiol 2000 23 : 544 549.
15. Bar-Cohen Y, Berul CI, Alexander ME, Fortescue EB, Walsh EP, Triedman JK, Cecchin F. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol 2006 17 : 754 759.
16. Bracke F, Meijer A, van Gelder B. Venous occlusion of the access vein in patients referred for lead extraction: Influence of patient and lead characteristics. Pacing Clin Electrophysiol 2003 26 : 1649 1652.
17. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004 27 : 924 932.
18. Nunain SO, Roelke M, Troton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, et al. Limitations and late complications of third generation automatic cardioverter defibrillators. Circulation 1995 91 : 2204 2213.
19. Eicken A, Kolb C, Lange S, Brodherr-Heberlein S, Zrenner B, Schreiber C, Hess J. Implantable cardioverter defibrillator in children. Int J Cardiol 2006 107 : 30 35.
20. Cooper JM, Stephenson EA, Berul CI, Walsh EP, Epstein LM. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: Implications for implantation and management. J Cardiovasc Electrophysiol 2003 14 : 344 349.
21. Friedman RA, Van Zandt H, Collins E, LeGras M, Perry J. Lead extraction in young patients with and without congenital heart disease using the subclavian approach. Pacing Clin Electrophysiol 1996 19 : 778 783.
22. Carlson MD, Wilkoff BL, Maisel WH, Carlson MD, Ellenbogen KA, Saxon LA, Prystowsky EN, et al. Recommendations from the Heart Rhythm Society Task Force on device performance policies and guidelines endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm 2006 3 : 1250 1273.
23. DeMaso DR, Lauretti A, Spieth L, van der Feen JR, Jay KS, Gauvreau K, Walsh EP, et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter defibrillators. Am J Cardiol 2004 93 : 582 587.
24. Stephenson EA, Cecchin F, Walsh EP, Berul CI. Utility of routine follow up defibrillator threshold testing in congenital heart disease and pediatric populations. J Cardiovasc Electrophysiol 2005 16 : 69 73.
25. Brodsky CM, Chang F, Vlay SC. Multicenter evaluation of implantable cardioverter defibrillator testing after implant: The Post-implant Testing Study (PITS). Pacing Clin Electrophysiol 1999 12 : 1769 1776.
26. Tummala RV, Riggio DR, Peters RW, Shorofsky SR, Gold MR. Chronic rise in defibrillation threshold with a hybrid lead system. Am J Cardiol 1996 78 : 309 312.
27. Stephenson EA, Batra AJ, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, et al. A Multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease populations. J Cardiovasc Electrophysiol 2006 17 : 41 46.
28. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter- defibrillators. J Am Coll Cardiol 1998 32 : 1909 1910.